Alan D. Feiger

937 total citations
16 papers, 708 citations indexed

About

Alan D. Feiger is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Alan D. Feiger has authored 16 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 6 papers in Experimental and Cognitive Psychology. Recurrent topics in Alan D. Feiger's work include Treatment of Major Depression (11 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Electroconvulsive Therapy Studies (4 papers). Alan D. Feiger is often cited by papers focused on Treatment of Major Depression (11 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Electroconvulsive Therapy Studies (4 papers). Alan D. Feiger collaborates with scholars based in United States, Canada and Spain. Alan D. Feiger's co-authors include Richard L. Rudolph, Ari Kiev, Ram Shrivastava, Charles S. Wilcox, Joshua D. Lipsitz, Moira A. Rynn, Karl Rickels, Dan Zimbroff, Donald S. Robinson and Jon F. Heiser and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Alan D. Feiger

16 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan D. Feiger United States 12 447 350 233 106 89 16 708
Charles S. Wilcox United States 16 320 0.7× 275 0.8× 272 1.2× 127 1.2× 73 0.8× 27 806
J O Cole United States 8 350 0.8× 353 1.0× 147 0.6× 89 0.8× 57 0.6× 10 583
Alessandra Signoretti Italy 7 319 0.7× 306 0.9× 155 0.7× 78 0.7× 91 1.0× 9 730
Robert E. McCue United States 17 475 1.1× 449 1.3× 154 0.7× 57 0.5× 127 1.4× 32 840
C.M.E. Kremer United States 13 651 1.5× 569 1.6× 179 0.8× 221 2.1× 158 1.8× 34 1.2k
Trisha L. Houser United States 8 424 0.9× 406 1.2× 236 1.0× 45 0.4× 84 0.9× 13 666
Jeffrey Apter United States 11 331 0.7× 245 0.7× 162 0.7× 240 2.3× 74 0.8× 18 806
Stephen Kaplita United States 9 268 0.6× 609 1.7× 198 0.8× 88 0.8× 48 0.5× 18 961
Meghan M. Grady United States 9 317 0.7× 334 1.0× 124 0.5× 137 1.3× 103 1.2× 16 808
A.R. Entsuah Canada 7 703 1.6× 388 1.1× 347 1.5× 189 1.8× 175 2.0× 12 983

Countries citing papers authored by Alan D. Feiger

Since Specialization
Citations

This map shows the geographic impact of Alan D. Feiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Feiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Feiger more than expected).

Fields of papers citing papers by Alan D. Feiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Feiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Feiger. The network helps show where Alan D. Feiger may publish in the future.

Co-authorship network of co-authors of Alan D. Feiger

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Feiger. A scholar is included among the top collaborators of Alan D. Feiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Feiger. Alan D. Feiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Feiger, Alan D., Karl Rickels, Moira A. Rynn, Dan Zimbroff, & Donald S. Robinson. (2006). Selegiline Transdermal System for the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 67(9). 1354–1361. 67 indexed citations
3.
Engelhardt, Nina, Alan D. Feiger, Kenneth O. Cogger, et al.. (2006). Rating the Raters. Journal of Clinical Psychopharmacology. 26(1). 71–74. 25 indexed citations
4.
Lipsitz, Joshua D., et al.. (2004). The Rater Applied Performance Scale: development and reliability. Psychiatry Research. 127(1-2). 147–155. 22 indexed citations
5.
Kobak, Kenneth A., Joshua D. Lipsitz, & Alan D. Feiger. (2003). Development of a standardized training program for the Hamilton Depression Scale using internet-based technologies: results from a pilot study. Journal of Psychiatric Research. 37(6). 509–515. 24 indexed citations
6.
Feiger, Alan D., Martine F. Flament, P Boyer, & John A. Gillespie. (2003). Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies. International Clinical Psychopharmacology. 18(4). 203–210. 17 indexed citations
7.
Feiger, Alan D., Jon F. Heiser, Ram Shrivastava, et al.. (2003). Gepirone Extended-Release. The Journal of Clinical Psychiatry. 64(3). 243–249. 44 indexed citations
8.
Feiger, Alan D., Martine F. Flament, P Boyer, & John A. Gillespie. (2003). Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies. International Clinical Psychopharmacology. 18(4). 203–210. 4 indexed citations
9.
Feiger, Alan D., Jon F. Heiser, Ram Shrivastava, et al.. (2002). Gepirone extended release (ER): New evidence for efficacy in the treatment of major depressive disorder (MDD). European Neuropsychopharmacology. 12. 230–230. 2 indexed citations
10.
Feiger, Alan D., Robert J. Bielski, J. Douglas Bremner, et al.. (1999). Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. International Clinical Psychopharmacology. 14(1). 19–28. 58 indexed citations
11.
Rudolph, Richard L. & Alan D. Feiger. (1999). A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression. Journal of Affective Disorders. 56(2-3). 171–181. 142 indexed citations
12.
Kiev, Ari & Alan D. Feiger. (1997). A Double-Blind Comparison of Fluvoxamine and Paroxetine in the Treatment of Depressed Outpatients. The Journal of Clinical Psychiatry. 58(4). 146–152. 73 indexed citations
13.
Feiger, Alan D., et al.. (1997). Efficacy of nefazodone in continuation treatment of depression. Biological Psychiatry. 42(1). 279S–279S. 3 indexed citations
14.
Shrivastava, Ram, et al.. (1996). Nefazodone vs. Sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. European Neuropsychopharmacology. 6. 48–48. 8 indexed citations
15.
Feiger, Alan D., et al.. (1996). Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.. PubMed. 57 Suppl 2. 53–62. 147 indexed citations
16.
Crowley, Thomas J., et al.. (1975). Monkey motor stimulation and altered social behavior during chronic methadone administration. Psychopharmacology. 43(2). 135–144. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles S. Wilcox Breakdown of academic impact, for papers by J O Cole Breakdown of academic impact, for papers by Alessandra Signoretti Breakdown of academic impact, for papers by Robert E. McCue Breakdown of academic impact, for papers by C.M.E. Kremer Breakdown of academic impact, for papers by Trisha L. Houser Breakdown of academic impact, for papers by Jeffrey Apter Breakdown of academic impact, for papers by Stephen Kaplita Breakdown of academic impact, for papers by Meghan M. Grady Breakdown of academic impact, for papers by A.R. Entsuah
Rankless by CCL
2026